Richardson, TXNCT05958381Now EnrollingIRB Ready

Multiple Sclerosis, Relapsing-Remitting Clinical Trial in Richardson, TX

Access cutting-edge multiple sclerosis, relapsing-remitting treatment through this clinical trial at a research site in Richardson. Study-provided care at no cost to qualified participants.

Sponsored by The University of Texas at Dallas

Quick Self-Assessment

See if you qualify for this Richardson location

Preparing your pre-screening questions…

Expert Care in Richardson

Access multiple sclerosis, relapsing-remitting specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple sclerosis, relapsing-remitting treatment provided free

Apply for This Richardson Location

Check if you qualify for this multiple sclerosis, relapsing-remitting clinical trial in Richardson, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Richardson

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Richardson site if eligible
  4. 4Begin participation

About This Multiple Sclerosis, Relapsing-Remitting Study in Richardson

The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in multiple sclerosis patients. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures. Additionally, the study will examine the degree to which baseline assessments of cognition and concussion history predict responses to treatment over time, both on assessments administered within the intervention period and at follow-up.

Sponsor: The University of Texas at Dallas

Who Can Participate

Inclusion Criteria

º Diagnosed with relapsing-remitting multiple sclerosis (RRMS) º Memory retrieval deficit based on neuropsychological testing done in our lab º Must be fluent in speaking and reading English.

Exclusion Criteria

º Relapse or acute MS exacerbation or a course of steroids in the two months preceding the testing º Participants using benzodiazepines must have been on a stable dose for at least two months º Potentially confounding psychological or neurological disorder, including:
dementia of any type
epilepsy or other seizure disorders
severe traumatic brain injury
brain tumor
present drug abuse
blood vessel abnormalities in the brain
Parkinson's disease
Huntington's disease º inability to give informed consent º cranial implants º skull defects that affect tDCS administration º use of medications that interact with or potentially interact with tDCS effects, including:
anti-convulsants
carbamazepine
rivastigmine
dextromethorphan
D-cycloserine
flunarizine
stimulants (dextroamphetamine/amphetamine/modafinil/armodafinil) must be stopped during enrollment

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Richardson?

Yes, this clinical trial (NCT05958381) has an active research site in Richardson, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Sclerosis, Relapsing-Remitting Treatment Options in Richardson, TX

If you're searching for multiple sclerosis, relapsing-remitting treatment options in Richardson, TX, this clinical trial (NCT05958381) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Richardson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis, relapsing-remitting specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple sclerosis, relapsing-remitting clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Richardson, TX

See all heart attack clinical trials recruiting in Richardson — not just this study.

Browse Heart Attack Trials in Richardson

Ready to Join in Richardson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Richardson, TX